CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 386 enrolled
Drug / intervention
BLI850 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00756548
NCT00756548Phase 3Completed
CompareCT.gov

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Braintree Laboratories·interventional·Posted Sep 22, 2008·Updated Dec 27, 2013

In Brief

A Phase 3 clinical trial evaluating BLI850 and polyethylene glycol 3350 based bowel preparation for Colon Cancer. Completed, enrolled 386 participants across 12 sites.

Detailed Summary

This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColon Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2008
Enrollment StartAug 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.8 years ago

Interventions

BLI850drug

multi-dose preparation for oral administration prior to colonoscopy

polyethylene glycol 3350 based bowel preparationdrug

multi-dose preparation for oral administration prior to colonoscopy